Luis López Lázaro

Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors

A. Taamma, J. L. Misset, M. Riofrio et al. · Journal of Clinical Oncology · 2001 · 160 citations

Erythema nodosum: Etiologic and predictive factors in a defined population

Carlos García‐Porrúa, Miguel Á. González‐Gay, Manuel Vázquez‐Caruncho et al. · Arthritis & Rheumatism · 2000 · 151 citations

Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies

Sandrine Faivre, Stéphanie Chièze, Catherine Delbaldo et al. · Journal of Clinical Oncology · 2005 · 99 citations · Full text

Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer

Jeany M. Rademaker-Lakhai, Simon Horenblas, W. Meinhardt et al. · Clinical Cancer Research · 2005 · 86 citations

A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.

Miguel A. Villalona‐Calero, S. Gail Eckhardt, Geoffrey R. Weiss et al. · PubMed · 2002 · 82 citations